Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-06 Sale | 2025-01-08 8:26 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 15,162 | $20.33 | $308,291 | 383,892 (Indirect Direct) | View |
| 2025-01-06 Sale | 2025-01-08 8:25 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 15,162 | $20.33 | $308,291 | 768,057 (Indirect Direct) | View |
| 2025-01-06 Sale | 2025-01-08 8:24 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 36,916 | $20.34 | $750,955 | 2,455,675 (Indirect Direct) | View |
| 2025-01-07 Sale | 2025-01-08 8:23 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 3,339 | $20.81 | $69,485 | 807,554 (Indirect Direct) | View |
| 2024-12-31 Sale | 2025-01-03 4:14 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 30,000 | $20.25 | $607,500 | 810,893 (Indirect Direct) | View |
| 2025-01-02 Sale | 2025-01-03 4:13 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 3,080 | $20.91 | $64,403 | 107,976 (Direct) | View |
| 2024-11-11 Sale | 2024-11-13 4:18 pm | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 59,441 | $32.51 | $1,932,665 | 66,684 (Indirect Direct) | View |
| 2024-11-07 Sale | 2024-11-12 4:44 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 15,558 | $29.91 | $465,286 | 755,194 (Indirect Direct) | View |
| 2024-11-07 Sale | 2024-11-12 4:43 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,020 | $30 | $30,600 | 111,056 (Direct) | View |
| 2024-11-01 Sale | 2024-11-05 4:21 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 3,080 | $27.07 | $83,376 | 112,076 (Direct) | View |
| 2024-10-18 Sale | 2024-10-22 4:30 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 40,000 | $27.69 | $1,107,600 | 3,516,502 (Indirect Direct) | View |
| 2024-09-30 Sale | 2024-10-02 4:37 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 30,000 | $29.03 | $870,900 | 840,893 (Indirect Direct) | View |
| 2024-09-13 Sale | 2024-09-16 4:17 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,020 | $30 | $30,600 | 115,156 (Direct) | View |
| 2024-09-03 Sale | 2024-09-04 6:26 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 3,080 | $25 | $77,007 | 116,176 (Direct) | View |
| 2024-08-20 Sale | 2024-08-22 4:16 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 2,260 | $23.79 | $53,765 | 2,438,411 (Indirect Direct) | View |
| 2024-08-20 Sale | 2024-08-22 4:15 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 1,727 | $23.79 | $41,085 | 870,893 (Indirect Direct) | View |
| 2024-08-20 Sale | 2024-08-22 4:14 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 8,353 | $23.99 | $200,401 | 701,815 (Indirect Direct) | View |
| 2024-08-20 Sale | 2024-08-22 4:14 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 22,458 | $24.49 | $549,928 | 327,029 (Indirect Direct) | View |
| 2024-08-13 Sale | 2024-08-15 4:10 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 2,272 | $22.89 | $52,006 | 710,168 (Indirect Direct) | View |
| 2024-08-13 Sale | 2024-08-15 4:09 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,337 | $22.89 | $53,494 | 349,487 (Indirect Direct) | View |
| 2024-06-13 Sale | 2024-07-03 9:13 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 30,688 | $22.11 | $678,660 | 872,620 (Indirect Direct) | View |
| 2024-07-01 Sale | 2024-07-03 9:13 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 3,080 | $22.14 | $68,204 | 119,256 (Direct) | View |
| 2024-06-06 Sale | 2024-06-10 8:06 pm | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 1,458 | $21.73 | $31,682 | 20,038 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-03 Option Award | 2025-06-05 5:02 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 73,955 | $0 | 3,479,348 (Indirect) | View |
Ownership | 2025-06-05 4:57 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 0 | $0 | 29,777,760 (Indirect) | View |
| 2025-06-03 Option Award | 2025-06-05 4:34 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 24,148 | $0 | 44,186 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:33 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director | 24,148 | $0 | 370,644 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:31 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Klein Peter S Director | 24,148 | $0 | 45,644 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:29 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 24,148 | $0 | 831,702 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:26 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 24,148 | $0 | 90,832 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:25 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director | 24,148 | $0 | 42,828 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:23 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 24,148 | $0 | 2,141,556 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 6:59 pm | N/A 2035-01-02 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 216,720 | $0 | 2,655,131 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 6:57 pm | N/A 2035-01-02 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 216,720 | $0 | 945,759 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 6:56 pm | N/A 2035-01-02 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 216,720 | $0 | 561,594 (Direct) | View |
| 2024-12-27 Exercise | 2024-12-31 4:18 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 6,708 | $5.28 | 775,710 (Direct) | View |
| 2024-12-27 Exercise | 2024-12-31 4:18 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 6,708 | $0 | 775,710 (Direct) | View |
| 2024-11-25 Exercise | 2024-11-27 4:44 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,845 | $0.68 | 452,029 (Direct) | View |
| 2024-11-25 Exercise | 2024-11-27 4:44 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,845 | $0 | 452,029 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-26 5:19 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 20,516 | $0.68 | 846,893 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-26 5:19 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 20,516 | $0 | 846,893 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-13 4:18 pm | N/A 2027-12-06 | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 47,165 | $0 | 66,684 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-13 4:18 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 47,165 | $18 | 66,684 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-12 4:44 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 15,558 | $5.28 | 755,194 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-12 4:44 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 15,558 | $0 | 755,194 (Direct) | View |
| 2024-10-18 Exercise | 2024-10-22 4:30 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 40,000 | $0.68 | 3,516,502 (Direct) | View |
| 2024-10-18 Exercise | 2024-10-22 4:30 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 40,000 | $0 | 3,516,502 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:33 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 23,868 | $0 | 921,209 (Direct) | View |